Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
3537TSE Standard

SHOEI YAKUHIN CO.,LTD.

昭栄薬品 Yahoo Finance

Recent & upcoming events

Aug 6
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 24
Shareholder meeting 21:00
Shareholders' meeting
Venue: 大阪市中央区内平野町３丁目２番５号 大阪薬業保健センター ７階 Details
Add to Google Calendar
May 14
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 29
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 21
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 15
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 8
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥26.92B YoY +7.6%
Operating income ¥505M margin 1.9%
Net income ¥557M YoY +5.6%
EPS ¥163 YoY +5.3%
P/E —
ROE 6.1% Equity ratio 53% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥27.27B +1.3%
Operating income ¥441M -12.6%
Net income ¥437M -21.6%
EPS ¥128 -21.6%

Quarterly fundamentals

Income & cash flow
Quarter FY22 Q4FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1
Revenue ¥6.44B¥5.48B¥5.57B¥5.54B¥5.84B¥5.64B
Operating income ¥153M¥24M¥98M¥138M¥141M¥64M
Net income ¥110M¥58M¥85M¥161M¥109M¥136M
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 9%個人 35.2%未開示 55.9%202120222023202420252026
事業法人海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

鐵野　磨輝男 11.5%鐵野　磨輝男大阪中小企業投資育成株式会社 9%大阪中小企業投資育成株式会社昭栄薬品社員持株会 8.1%昭栄薬品社員持株会藤原　佐一郎 3%藤原　佐一郎小林　節夫 3%小林　節夫渡邉　健司 2.3%渡邉　健司岩井　伸太郎 2.1%岩井　伸太郎雨森　肇 1.9%雨森　肇成瀬　幸次 1.7%成瀬　幸次小池　宏美 1.6%小池　宏美202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
鐵野 磨輝男 395,205 11.5% Yuho (EDINET)
大阪中小企業投資育成株式会社 307,500 9.0% Yuho (EDINET)
昭栄薬品社員持株会 278,385 8.1% Yuho (EDINET)
藤原 佐一郎 102,000 3.0% Yuho (EDINET)
小林 節夫 101,700 3.0% Yuho (EDINET)
渡邉 健司 77,000 2.3% Yuho (EDINET)
岩井 伸太郎 72,000 2.1% Yuho (EDINET)
雨森 肇 65,215 1.9% Yuho (EDINET)
成瀬 幸次 57,045 1.7% Yuho (EDINET)
小池 宏美 55,595 1.6% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

7/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 3.1%
✓ Positive operating cash flow ¥104M
✓ ROA improved YoY 3.1% → 3.1%
✗ Operating CF exceeds net income (accrual quality) OCF ¥104M / net income ¥557M
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 52.3% → 52.9%
✓ Current ratio improved 1.64× → 1.68×
✓ No dilution (shares outstanding did not increase) 3,579,105 → 3,579,105
✗ Gross margin improved 8.4% → 8.0%
✓ Asset turnover improved 1.46× → 1.51×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 52.9%
Current ratio 1.7×
Years of positive operating CF 7 of last 10 yrs
Payout ratio 29%
Latest fiscal year result Profit (net income ¥557M)

Performance history

Last 10 years
0億円67億円135億円202億円269億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 188202201177170211245226250269
Operating income 2.983.352.741.281.583.024.884.405.605.05
Ordinary income 3.894.524.112.623.134.756.746.527.587.25
Net income 2.613.142.732.562.385.794.854.925.275.57
Total assets 140171168150146145148168171178
Equity 63.176.680.881.476.469.573.781.489.494.2

Indicators & cash flow

*Split-adjustedUnit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥73¥88¥77¥72¥68¥167¥142¥145¥155¥163
ROE 4.3%4.5%3.5%3.2%3.0%7.9%6.8%6.3%6.2%6.1%
Operating CF 0.6611.13.32-4.723.25-3.986.458.18-1.721.04
Investing CF -1.03-0.40-0.331.160.393.83-0.30-0.18-0.213.17
Financing CF -2.15-3.54-5.05-5.47-0.77-0.62-2.69-1.72-1.29-5.83
FCF -0.3610.72.99-3.563.64-0.166.148.00-1.934.21

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data